Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes

P.6.b.009 Deletion of cannabinoid receptor 2 increased ethanol abuse vulnerability associated to alterations in m-opioid receptor gene expression in mice

(2011) A. Ortega-Alvaro et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Mechanisms of antidepressant action: An integrated dopaminergic perspective

(2011) S. Porcelli et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes

(2011) Antonio Drago et al.   PROGRESS IN NEUROBIOLOGY

Personalized medicine can pave the way for the safe use of CB1 receptor antagonists

(2011) Judit Lazary et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Genes, Environment, and Individual Differences in Responding to Treatment for Depression

(2011) Rudolf Uher   HARVARD REVIEW OF PSYCHIATRY

Using gene–environment interactions to target personalized treatment in mood disorder

(2010) Torsten Klengel et al.   Personalized Medicine

Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression

(2010) Palmiero Monteleone et al.   PHARMACOLOGICAL RESEARCH

Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder?

(2009) William S. Gilmer et al.   JOURNAL OF CLINICAL PSYCHIATRY

Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients

(2009) M. Vermeiden et al.   JOURNAL OF PSYCHOPHARMACOLOGY

CNR1 Gene is Associated with High Neuroticism and Low Agreeableness and Interacts with Recent Negative Life Events to Predict Current Depressive Symptoms

(2009) Gabriella Juhasz et al.   NEUROPSYCHOPHARMACOLOGY

Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors

(2009) Bárbara Arias et al.   Pharmacogenetics and Genomics

Pharmacogenomics of antidepressant drugs

(2009) Sonja Horstmann et al.   PHARMACOLOGY & THERAPEUTICS

Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression

(2008) Katharina Domschke et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei

(2008) Juan Suárez et al.   JOURNAL OF COMPARATIVE NEUROLOGY

Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

(2008) I. Racz et al.   JOURNAL OF NEUROSCIENCE

Interferon-  Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain

(2008) I. Racz et al.   JOURNAL OF NEUROSCIENCE

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

(2008) M Kato et al.   MOLECULAR PSYCHIATRY

Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects

(2008) Emmanuel S. Onaivi et al.   PLoS One

Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?

(2008) M. J. Arranz et al.   SCHIZOPHRENIA BULLETIN

CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus

(2007) Tamás Balázsa et al.   NEUROCHEMISTRY INTERNATIONAL